Monday 9/9 Insider Buying Report: ACHC, ESPR

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy — they expect to make money. So let's look at two noteworthy recent insider buys.

On Thursday, Acadia Healthcare Company's Chief Executive Officer, Debra K. Osteen, made a $530,660 purchase of ACHC, buying 20,000 shares at a cost of $26.53 each. Osteen was up about 9.6% on the buy at the high point of today's trading session, with ACHC trading as high as $29.08 at last check today. Acadia Healthcare Company is trading up about 5.6% on the day Monday. This purchase marks the first one filed by Osteen in the past twelve months.

And on Friday, CEO Timothy M. Mayleben bought $259,107 worth of Esperion Therapeutics, buying 7,500 shares at a cost of $34.55 each. Before this latest buy, Mayleben purchased ESPR on 5 other occasions during the past year, for a total investment of $1.09M at an average of $43.55 per share. Esperion Therapeutics is trading up about 1.9% on the day Monday. So far Mayleben is in the green, up about 4.1% on their purchase based on today's trading high of $35.97.

VIDEO: Monday 9/9 Insider Buying Report: ACHC, ESPR

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.